National mycology laboratory diagnostic capacity for invasive fungal diseases in 2017: Evidence of sub-optimal practice
- PMID: 31233810
- DOI: 10.1016/j.jinf.2019.06.009
National mycology laboratory diagnostic capacity for invasive fungal diseases in 2017: Evidence of sub-optimal practice
Abstract
A survey of laboratory testing capabilities for systemic fungal pathogens was undertaken in the UK, to identify where improved compliance with published standards and guidelines is required and to inform antifungal stewardship (AFS). The survey captured information from laboratories in the UK on diagnostic capacity for invasive fungal diseases (IFD), including identification, serology, molecular diagnostics and susceptibility testing. The survey was circulated in March 2017 through key networks. Of 154 laboratories providing diagnostic mycology services in the UK, 80 (52%) responded to the survey. Results indicated that 85% of respondents identified fungal isolates from high risk patients to species level, and that many laboratories (78%) could access local susceptibility testing for yeasts, whereas 17% could for Aspergillus species. However, direct microscopy was only used in 49% as a first line investigation on samples where it would be appropriate. A low number of respondents identified yeasts cultured from intravascular line tips to species level (63%) and even fewer fully identified urine isolates from critically ill patients (42%) or the immunocompromised (39%). Less than half of respondents advised therapeutic drug monitoring (TDM) for flucytosine. Few laboratories had access to local β-glucan (4%) or galactomannan (20%) testing. The survey highlights that the current level of fungal diagnostics in the UK is below accepted best practice with an urgent need to improve across many diagnostic areas including the timely accessibility of fungal biomarkers, susceptibility testing and provision of TDM testing. Improvements are important to facilitate the delivery of diagnostic driven AFS strategies as well as appropriate management of IFD.
Keywords: Audit; British Society for Medical Mycology; Diagnostic capacity; Invasive fungal infections; Standards of care; UK Clinical Mycology Network.
Copyright © 2019 The British Infection Association. All rights reserved.
Similar articles
-
Laboratory and clinical management capacity for invasive fungal infections: the Italian landscape.Infection. 2024 Feb;52(1):197-208. doi: 10.1007/s15010-023-02084-x. Epub 2023 Sep 1. Infection. 2024. PMID: 37656348 Free PMC article.
-
Clinicians' challenges in managing patients with invasive fungal diseases in seven Asian countries: An Asia Fungal Working Group (AFWG) Survey.Int J Infect Dis. 2020 Jun;95:471-480. doi: 10.1016/j.ijid.2020.01.007. Epub 2020 Jan 13. Int J Infect Dis. 2020. PMID: 31945491
-
Candida and candidaemia. Susceptibility and epidemiology.Dan Med J. 2013 Nov;60(11):B4698. Dan Med J. 2013. PMID: 24192246 Review.
-
Mycology laboratory diagnostic capacity for invasive fungal diseases in public hospitals in Vietnam.Med Mycol. 2024 Aug 2;62(8):myae082. doi: 10.1093/mmy/myae082. Med Mycol. 2024. PMID: 39122653 Free PMC article.
-
Candida and invasive mould diseases in non-neutropenic critically ill patients and patients with haematological cancer.Lancet Infect Dis. 2017 Nov;17(11):e344-e356. doi: 10.1016/S1473-3099(17)30304-3. Epub 2017 Jul 31. Lancet Infect Dis. 2017. PMID: 28774702 Review.
Cited by
-
Antifungals: From Pharmacokinetics to Clinical Practice.Antibiotics (Basel). 2023 May 9;12(5):884. doi: 10.3390/antibiotics12050884. Antibiotics (Basel). 2023. PMID: 37237787 Free PMC article. Review.
-
Azole resistance in Aspergillus fumigatus- comprehensive review.Arch Microbiol. 2024 Jun 15;206(7):305. doi: 10.1007/s00203-024-04026-z. Arch Microbiol. 2024. PMID: 38878211 Review.
-
Quality improvement project to reduce beta-D-glucan turnaround times in an NHS pathology network.BMJ Open Qual. 2025 May 6;14(2):e003210. doi: 10.1136/bmjoq-2024-003210. BMJ Open Qual. 2025. PMID: 40328642 Free PMC article.
-
The Role of Diagnostics-Driven Antifungal Stewardship in the Management of Invasive Fungal Infections: A Systematic Literature Review.Open Forum Infect Dis. 2022 May 11;9(7):ofac234. doi: 10.1093/ofid/ofac234. eCollection 2022 Jul. Open Forum Infect Dis. 2022. PMID: 35873300 Free PMC article. Review.
-
Trends in the activity of mold-active azole agents against Aspergillus fumigatus clinical isolates with and without cyp51 alterations from Europe and North America (2017-2021).J Clin Microbiol. 2024 Feb 14;62(2):e0114123. doi: 10.1128/jcm.01141-23. Epub 2024 Jan 9. J Clin Microbiol. 2024. PMID: 38193696 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical